1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA CDC7 CTRPv2 pan-cancer AAC -0.092 0.01
mRNA REL CTRPv2 pan-cancer AAC -0.092 0.01
mRNA MAFF CTRPv2 pan-cancer AAC 0.1 0.01
mRNA PALB2 CTRPv2 pan-cancer AAC 0.088 0.01
mRNA EXOC2 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA FXR1 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA ARPC4 CTRPv2 pan-cancer AAC 0.088 0.01
mRNA SEC14L6 CTRPv2 pan-cancer AAC 0.11 0.01
mRNA PSMC4 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA CRACR2B CTRPv2 pan-cancer AAC 0.094 0.01
Download CSV